← All drug classes
Drug class · FAERS comparison

Quinolone Antimicrobial side effects compared: 4 drugs, 21,927 FDA adverse event reports

Class as assigned in the FDA label (Established Pharmacologic Class) · data 2026-09-14
How to read this page. Report counts are not incidence rates: a drug with more reports is usually older, more widely used or more publicised, not more dangerous. Signals are screened against each product's FDA label on its own page; a term flagged across most of a class usually reflects the shared mechanism or the shared patient population.

Members

DrugFAERS reportsSeriousDeath outcomeBoxed warningTop labeled signalsUnlabeled (unassessed)
Ofloxacin (Ofloxacin Otic)7,17077%608–Eye pain; Eye inflammationChronic kidney disease; Eye irritation
Ofloxacin Otic (Ofloxacin)6,94077%573–Eye pain; Eye inflammationChronic kidney disease; Eye irritation
Ofloxacin Otic (Ofloxacin)6,85077%573–Eye pain; Eye inflammationChronic kidney disease; Eye irritation
Besifloxacin (Besivance)96744%67–Eye pain; Vision blurred; Eye irritationOcular hyperaemia; Cardiac disorder

Class-wide signals (flagged in at least 2 of 4 members)

ReactionMembers flaggedMedian PRRReports (sum)In label
Eye pain4/418.41,1164/4 members' labels
Eye inflammation4/417.11803/4 members' labels
Ocular discomfort4/415.31840/4 members' labels
Photophobia4/413.72900/4 members' labels
Eye infection4/412.71520/4 members' labels
Eye discharge4/410.61270/4 members' labels
Eye irritation4/48.55451/4 members' labels
Lacrimation increased4/47.62430/4 members' labels
Chronic kidney disease4/47.66160/4 members' labels
Ocular hyperaemia4/46.93820/4 members' labels
Eye swelling4/46.62700/4 members' labels
Visual acuity reduced4/45.92140/4 members' labels
Cataract4/45.93760/4 members' labels
Tendonitis3/425.03840/3 members' labels
Toxic epidermal necrolysis3/415.52310/3 members' labels
Tendon rupture3/412.41520/3 members' labels
Vitreous floaters3/410.3990/3 members' labels
Toxic skin eruption3/410.21020/3 members' labels
Hepatic cytolysis3/49.71170/3 members' labels
Cholestasis3/49.01710/3 members' labels
End stage renal disease3/48.71600/3 members' labels
Agranulocytosis3/48.21500/3 members' labels
Neuralgia3/48.11960/3 members' labels
Muscle atrophy3/48.11030/3 members' labels
Conjunctivitis3/47.61410/3 members' labels
Rash maculo-papular3/47.01530/3 members' labels
Eosinophilia3/46.61140/3 members' labels
Blindness unilateral3/46.5930/3 members' labels
Drug reaction with eosinophilia and systemic symptoms3/46.41620/3 members' labels
Hepatocellular injury3/46.4900/3 members' labels

Member-specific signals (flagged in exactly one drug)

ReactionDrugReportsPRRLabel screen
Vision blurredBesifloxacin8112.9Labeled (related wording)
Cardiac disorderBesifloxacin5011.6Not in label — unassessed

Common questions

Which quinolone antimicrobial has the most FDA adverse event reports?

Ofloxacin has the most FAERS co-reports in this class (7,170), followed by Ofloxacin Otic (6,940). Report volume tracks how widely and how long a drug has been used, and how much attention it has had, far more than its risk.

Which side effects are shared across quinolone antimicrobial drugs?

Reaction terms flagged in at least half of the 4 members include eye pain, eye inflammation, ocular discomfort, photophobia, eye infection. A term shared across a class usually reflects the shared mechanism (or the shared patient population) rather than one product.

Does a FAERS signal mean the drug causes the reaction?

No. These are disproportionality signals from voluntary reports with no denominator. Each is screened against the FDA label (known vs unlabeled) on the drug pages; causality needs temporality, dose-response, plausibility and trial or cohort evidence.

Sources: openFDA FAERS pair statistics (OpenPV build 2026-09-14), FDA labels via openFDA, seriousness and death counts from openFDA count queries. Generated 2026-10-08. Not medical advice.